Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy [seq]
Ontology highlight
ABSTRACT: Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy [seq]
PROVIDER: PRJNA1170853 | ENA |
REPOSITORIES: ENA
ACCESS DATA